Lilly’s weight-loss pill wins US approval, sets up next battle with rival Novo Nordisk Reuters FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions investor.lilly.com Lilly’s obesity pill gets US approval in challenge to Novo Yahoo Finance Oral Alternative to Ozempic May... Read More








:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)





Recent Comments